Oscar Health (OSCR) Common Equity (2020 - 2026)

Oscar Health has reported Common Equity for 7 years, with the latest figure at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 24.77% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 24.77% YoY), and the FY2025 full-year result was $977.6 million, up 33546.73% from the prior year.
• Common Equity for Q1 2026 stood at $1.7 billion, up from $977.6 million in the prior quarter.
• The five-year high for Common Equity was $1.7 billion in Q1 2026, with the low at -$2.8 billion in Q2 2025.
• Historically, Common Equity has averaged $417.0 million across 5 years, with a median of $931.8 million in 2023.
• The largest YoY upside for Common Equity was 66805650.0% in 2025 against a maximum downside of 140218750.0% in 2025.
• Oscar Health's Common Equity stood at -$2.6 billion in 2022, then surged by 130.93% to $806.1 million in 2023, then plunged by 100.36% to -$2.9 million in 2024, then surged by 33546.73% to $977.6 million in 2025, then surged by 70.52% to $1.7 billion in 2026.
• The last three Common Equity figures came in at $1.7 billion (Q1 2026), $977.6 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.